Alpha Teknova (TKNO) Preferred Stock Liabilities (2020)
Alpha Teknova (TKNO) posted quarterly Preferred Stock Liabilities of $35.6 million for Q4 2020.
Alpha Teknova (TKNO) Preferred Stock Liabilities (2020) Analysis & Trends
Alpha Teknova (TKNO) has reported Preferred Stock Liabilities for 1 consecutive years, with $35.6 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Preferred Stock Liabilities changed N/A year-over-year to $35.6 million; the TTM figure through Dec 2020 stood at $35.6 million (changed N/A YoY), while the FY2020 annual figure was $35.6 million, changed N/A from the prior year.
- Preferred Stock Liabilities was little changed at $35.6 million in Q4 2020 per TKNO's latest filing.
- Across five years, Preferred Stock Liabilities topped out at $35.6 million in Q4 2020 and bottomed at $35.6 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alpha Teknova | 396.90 Mn | 379.46 Mn | 4.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 35.64 Mn |